Veradermics Logo

Veradermics

🇺🇸
MANE
US9229671048

Veradermics is a US clinical-stage biopharmaceutical company developing prescription therapies for dermatological conditions. Its pipeline focuses on treatments for androgenetic hair loss as well as other skin disorders such as warts.

Next Quarterly Earnings

Monday, March 29, 2027
Expected

Stock Price

Frequently asked questions

When did Veradermics last report quarterly earnings?

Veradermics last reported quarterly earnings on 8/11/2026 (Q2 2026). Earnings per share (EPS) came in at -0.58 USD.

How do I add the Veradermics earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q2 2026
Beat
Estimate:-$0.65
Actual:-$0.58
Difference:+$0.07
Q1 2026
Missed
Estimate:-$0.64
Actual:-$1.20
Difference:-$0.56
Price reaction (1 day):-3.9 %
Price reaction (7 days):-7.5 %
Q4 2025
Estimate:
Actual:-$3.39
Price reaction (1 day):-7.1 %
Price reaction (7 days):-2.6 %

Company Information

Name
Veradermics
Ticker Symbol
MANE
ISIN
US9229671048
Country
🇺🇸
USA
Sector
More Financial Information